Alto Capital's Tony Locantro touches on Mako Gold Ltd (ASX:MKG)'s quarterly report which was out this morning as well as recent news from Alta Zinc Ltd (ASX:AZI) which has received funding support for an innovative remote sensing and laser project through the EIT Raw Materials program at its Gorno Zinc Project in northern Italy. Locantro also offers up his thoughts on an update from Chimeric Therapeutics Ltd (ASX:CHM) which has licensed a novel cancer therapy for solid tumours from a world-renowned cell therapy centre.
Tony Locantro says Mako Gold well cashed-up and delivering consistent results
Quick facts: Mako Gold Ltd
Price: 0.093 AUD
Market Cap: $35.55 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...FOR OUR FULL DISCLAIMER CLICK HERE